Microbial identification is key for non-sterile facilities producing pharmaceuticals or nutraceuticals. Accugenix reviews modern identification methods for use in environmental monitoring programmes
For manufacturers of pharmaceuticals, dietary supplements or nutraceuticals, the presence of bacteria, filamentous fungi and yeasts are usually a cause for concern. However, a well-designed environmental monitoring (EM) programme should detect the presence of these micro-organisms before product contamination occurs.
When bacterial or fungal isolates are recovered from a production facility, it is important to be able to identify accurately the organism to the species, and possibly strain level, to track the potential origin of the contamination, mitigate it and avoid delays in product release or to complete investigations.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.